Efficacy and Safety of Sugammadex in High-Risk Ambulatory Surgeries
Status:
Withdrawn
Trial end date:
2020-07-20
Target enrollment:
Participant gender:
Summary
In this randomized controlled study, the investigators hypothesize that sugammadex is
superior to neostigmine in higher risk patients undergoing laparoscopic outpatient surgery in
an urban, stand-alone ambulatory surgery center.
The primary objective of this study is to evaluate the "fit to discharge time in the PACU."
The secondary objectives are PACU adverse events, use of additional medications in the PACU,
0-30 day ED or inpatient admissions for a pulmonary diagnosis and patient satisfaction at
discharge.